Neurodegenerative Disease Technologies

Compounds to Modulate Retinoid X Receptors

Bi-specific Antibodies as a Therapeutic for Alzheimer’s Disease

Antibody based reagents that specifically recognize toxic oligomeric forms of beta-amyloid

Selective Clearance of Beta-Amyloid Using Bispecific Recombinant Antibody fragments

Compounds to Modulate Retinoid X Receptors

Recombinant Antibody Fragments that Selectively Target Oligomeric Tau Aggregates

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Compounds to Modulate Retinoid X Receptors

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury

Reagents Targeting Neurodegenerative Diseases and Traumatic Brain Injury